Canada markets closed
  • S&P/TSX

    19,991.88
    +105.94 (+0.53%)
     
  • S&P 500

    4,207.27
    -2.97 (-0.07%)
     
  • DOW

    33,336.67
    +27.16 (+0.08%)
     
  • CAD/USD

    0.7835
    +0.0006 (+0.07%)
     
  • CRUDE OIL

    94.22
    +2.29 (+2.49%)
     
  • BTC-CAD

    30,865.16
    +399.29 (+1.31%)
     
  • CMC Crypto 200

    573.03
    -1.72 (-0.30%)
     
  • GOLD FUTURES

    1,803.60
    -10.10 (-0.56%)
     
  • RUSSELL 2000

    1,975.26
    +6.01 (+0.31%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • NASDAQ

    12,779.91
    -74.89 (-0.58%)
     
  • VOLATILITY

    20.20
    +0.46 (+2.33%)
     
  • FTSE

    7,465.91
    -41.20 (-0.55%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • CAD/EUR

    0.7585
    -0.0012 (-0.16%)
     

Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at H.C. Wainwright’s 2nd Annual Psychedelics Conference and Stifel’s 2nd Annual Future of Healthcare Conference in December.

H.C. Wainwright’s 2nd Annual Psychedelics Conference
Field Trip’s Co-Founder and CEO, Joseph Del Moral, and Chief Scientific Officer, Dr. Nathan Bryson, will present live at H.C. Wainwright’s 2nd Annual Psychedelics Conference taking place on Monday, December 6th. A recording of Field Trip’s presentation will be available on-demand from Monday, December 6th at 7:00a.m. Eastern Time, through the following link: https://journey.ct.events/view/c5617d9d-c81a-4cc7-b81d-754d93bb10be.

Stifel’s 2nd Annual Future of Healthcare Conference
Field Trip’s Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will present live at the Stifel Virtual Healthcare Conference on Wednesday, December 8th at 12:30p.m. Eastern Time. To view the presentation, please register via this link: https://wsw.com/webcast/stifel62/register.aspx?conf=stifel62&page=ftrp&url=https://wsw.com/webcast/stifel62/ftrp/2112420.

Recordings of the presentations will be accessible on Field Trip’s investor relations website via the above links for 90 days.

Field Trip’s management team will be available for one-on-one meetings throughout the duration of the conferences. To schedule a meeting with Field Trip’s management team, please contact KCSA Strategic Communications at fieldtripIR@kcsa.com.

About Field Trip Health Ltd.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics and our Field Trip Health division building centres for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, we help people in need with a simple, evidence-based way to heal and heighten engagement with the world.

Learn more at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

Follow us on Twitter and Instagram: @fieldtriphealth.

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

Cautionary Note Regarding Forward-Looking Information

This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding Field Trip and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of Field Trip and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including those set forth in the Company’s Annual Information Form and other market conditions, economic factors, management's ability to manage and to operate the business and the equity markets generally. Although Field Trip has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to Field Trip, including its Annual Information Form, can be located on the SEDAR website at www.sedar.com and on the EDGAR section of the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

Neither the Toronto Stock Exchange, nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.

CONTACTS:

Media contacts:
Rachel Moskowitz
Autumn Communications
202-276-7881
press@fieldtriphealth.com

Nick Opich / McKenna Miller
KCSA Strategic Communications
212-896-1206 / 347-487-6197
press@fieldtriphealth.com

Investor contacts:
Kathleen Heaney / Tim Regan
KCSA Strategic Communications
fieldtripIR@kcsa.com

SOURCE Field Trip Health Ltd.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting